Sort
141,003 grants matching “cytokine”
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
$3,571,550Jay A Berzofsky · Division Of Clinical Sciences - Nci · ZIA · FY2013 · CA
WOMENS INTERAGENCY HIV STUDY (WIHS)
$3,568,374University Of Southern California · U01 · FY2002 · HD
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$3,566,145John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK
Post-Irradiation Intervention to Mitigate and Treat Non Hematological Radiation
$3,560,891John E Moulder · Medical College Of Wisconsin · U19 · FY2009 · AI
THERAPY OF CML
$3,556,156Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2006 · CA
Viral Hemorrhagic Fevers: Disease Modeling and Transmission
$3,552,426Heinrich Feldmann · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
THERAPY OF CML
$3,552,240Richard E. Champlin · University Of Tx Md Anderson Can Ctr · P01 · FY2007 · CA
Interferon Signaling in the T1D Islet Microenvironment
$3,546,985Raghavendra G Mirmira · University Of Chicago · U01 · FY2025 · DK
Human Translational Studies of Inflammation and Cardiometabolic Diseases: The Psoriasis, Atherosclerosis and Cardiometabolic disease (PACI) Initiative
$3,542,612Nehal Mehta · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
THERAPY OF CML
$3,538,057University Of Texas Md Anderson Can Ctr · P01 · FY2005 · CA
Stat transcription factors in immunoregulation and autoimmune disease
$3,535,246John O'Shea · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2018 · AR
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,535,017Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2021 · AI
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
$3,534,431Katharina Maria Busl · University Of Florida · U01 · FY2024 · NS
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
$3,533,187Yvonne W Wu · University Of California, San Francisco · U01 · FY2020 · NS
Growth Control in Multiple Myeloma
$3,532,781Bart Barlogie · Univ Of Arkansas For Med Scis · P01 · FY2008 · CA
Targeted disruption the enzymes of O-GlcNAc cycling: Animal models of Disease
$3,526,723John A. Hanover · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2020 · DK
Factors Contributing to Oral Health Disparities in Appalachia
$3,515,593Mary L Marazita · University Of Pittsburgh At Pittsburgh · R01 · FY2019 · DE
Pterygopalatine Fossa (PPF) Block as an Opioid Sparing Treatment for AcuteHeadache in Aneurysmal Subarachnold Hemorrhage
$3,514,491Katharina Maria Busl · University Of Florida · U01 · FY2023 · NS
Lipid and Lipoprotein Metabolism in Atherosclerosis
$3,512,187Alan M Fogelman · University Of California Los Angeles · P01 · FY2007 · HL
NATIENS: A Phase III Randomized Double Blinded Study to Determine the Mechanisms and Optimal Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
$3,507,424Elizabeth Phillips · Vanderbilt University Medical Center · U01 · FY2023 · AI
Influenza and Emerging Infectious Diseases
$3,504,680Richard Davey · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Advancing Islet Transplants for Type 1 Diabetes Care
$3,500,000University Of Minnesota Twin Cities · U01 · FY2004 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2023 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2024 · AI
High resolution longitudinal immune monitoring for elucidating immune aging dynamics
$3,500,000Mark M Davis · Stanford University · P01 · FY2022 · AI